COMMENTARY: Addition of graduated compression stockings to fondaparinux did not reduce risk for venous thromboembolism after hip surgery
- Addition of graduated compression stockings to fondaparinux did not reduce risk for venous thromboembolism after hip surgery. // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p21
The article presents a clinical study that evaluates the efficacy of the combination of fondaparinux and graduated compression stockings in preventing venous thromboembolism in patients who were having hip surgery. A randomized controlled study was conducted on 856 patients ages from 18 to 99...
- Anticoagulation promises and pitfalls. Turpie, Alexander G.G.; Weart, C. Wayne; White, Richard; Pinkowish, Mary Desmond // Patient Care;4/15/1998, Vol. 32 Issue 7, p106
Focuses on anticoagulant therapy which reduces the morbidity and mortality associated with thromboembolic disease. Reference to surveys which suggest that physicians are hesitant to use oral anticoagulants in certain situations; Details on changes made in anticoagulation therapy; Reasons cited...
- Anticoagulants in venous thromboembolism. Fennerty, A.; Campbell, I.A. // BMJ: British Medical Journal (International Edition);11/19/88, Vol. 297 Issue 6659, p1285
Examines the effects of anticoagulants in venous thromboembolism. Use of heparin and warfarin to treat deep vein thrombosis and pulmonary embolism; Influence of heparin in the incidence of hemorrhage; Relation between hemorrhage incidence and prothrombin time.
- The use of long-term low-molecular weight heparin for the treatment of venous thromboembolism in palliative care patients with advanced cancer: a case series of sixty two patients. Noble, S. I. R.; Hood, K.; Finlay, I. G. // Palliative Medicine;Sep2007, Vol. 21 Issue 6, p473
The advantages of low-molecular weight heparin (LMWH) over warfarin, in the treatment of cancer associated venous thromboembolism (VTE) are well reported. However the studies supporting LMWH include few patients representative of the palliative care population. Although LMWH has advantages over...
- Pharmacological prevention of venous thromboembolism in orthopaedic surgery. Prisco, Domenico; Cenci, Caterina; Silvestri, Elena; Emmi, Giacomo; Ciucciarelli, Lucia // Clinical Cases in Mineral & Bone Metabolism;2014, Vol. 11 Issue 3, p192
The prophylaxis of venous thromboembolism (VTE) with anticoagulant drugs is a long-established practice in hip and knee replacement surgery, as well as in the treatment of femoral neck fractures, while there are few data regarding the prevention of VTE in other fields of orthopaedic surgery and...
- To prevent thromboembolism, give oral anticoagulants for 6 months, not 6 weeks. // Modern Medicine;Oct95, Vol. 63 Issue 10, p50
Presents an abstract of the article `A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism,' by S. Schulman, A.-S. Rhedin, P. Lindmarker, et al from the `New England Journal of Medicine' dated June 22, 1995.
- Extending anticoagulant regimen helps prevent thromboembolisms. // Formulary;Oct95, Vol. 30 Issue 10, p621
Presents an abstract of the medical study `A Comparison of Six Weeks With Six Months of Oral Anticoagulant Therapy After a First Episode of Venous Thromboembolism,' by S. Schulman, A-S Rhedin et al, published in the North England Journal of Medicine 1995.
- Anticoagulation. Cromheecke, M.E.; Levi, M.; Colly, L.P.; Crowther, M.A.; Julian, J.; McCarty, D. // Annals of Internal Medicine;1/15/2002, Vol. 136 Issue 2, p139
Examines the effectiveness of the administration of anticoagulant on patients with thromboembolism. Feasibility of self-management anticoagulant therapy; Appreciation of patients on the process of administering the anticoagulant; Decrease occurrence of bleeding on patients receiving...
- Is long-term anticoagulation after acute thromboembolic limb ischemia always necessary? Forbes, Thomas L.; DeRose, Guy; Harris, Kenneth A. // Canadian Journal of Surgery;Oct2002, Vol. 45 Issue 5, p337
Examines the efficacy of anticoagulant therapy in preventing the recurrence of thromboembolic limb ischemia. Incidence of recurrent emboli in patients with atrial fibrillation; Complications of the therapy; Causes of arterial thromboembolism.